Considering the large number of cell experiments proving that HIF-1α contributes to the chemoresistance of ovarian cancer (discussed later) and the small number of samples in the studies mentioned previously, we need to further investigate the relationship between HIF-1α expression and chemotherapy sensitivity (Table 1). The gene discussed is HIF1A; the disease is ovarian carcinoma.